Florida Democratic Party Chair Slams Congress Over Federal Hemp Ban, Saying Her State Will Legalize Marijuana Next Year

November 27, 2025

Federal hemp ban, served cold: a gut-punch in the dark

The federal hemp ban wasn’t a debate, it was a blindside—slipped into a must-pass spending bill and signed by President Donald Trump, a late-night special that will outlaw most consumable hemp products next November. One stroke, and a multi-billion-dollar market—built under the 2018 Farm Bill, scaled by grit, and stocked by mom-and-pop operators—is staring down the barrel of forced extinction. Florida Democratic Party chair Nikki Fried calls it gut-wrenching. She talks about small farmers who mortgaged their futures, storefronts that finally hit positive cash flow, and a consumer base that found relief on bottom shelves instead of behind pharmacy counters. Her prediction is not subtle: Congress made a mess, and lawmakers will have no choice but to mop it up. You can taste the panic—confusion, fear, anger—rising from a 400,000-plus-job engine suddenly told the rules were different, again. That’s the American cannabis story in one line: build fast, pivot faster, and try not to get crushed by the next federal swerve.

What Congress missed while everyone was sleeping

The ban zeroes in on consumable hemp products—the gummies in glove compartments, tinctures on nightstands, seltzers in fridges—after years of Washington shrugging at a patchwork shaped by states and hustling entrepreneurs. Fried says this isn’t an abstract policy tweak. It’s the poker-night gummies that let a grandmother keep her edge without a hangover. It’s the veteran who prefers a hemp-derived alternative to an Rx cocktail from the VA. It’s the quiet migration away from opioids, one bottle of CBD at a time. In other words, real people. And yes, there are safety questions worth regulating: testing standards, QR codes, age gates, pesticide bans. That’s what rules are for. Instead, Congress used a sledgehammer where a scalpel would do. Meanwhile, even the wonky corners of federal health are moving in the opposite direction—nudging toward access for older Americans, as explored in Federal Health Agency Moves To Allow CBD Coverage Under Medicare, As Promoted In Video Trump Posted. The contradiction is almost artful: criminalize one aisle while considering coverage for another.

“Yea, y’all f**ked up real bad here. Farmers, small businesses, veterans, seniors, 400k plus jobs … This is why people hate government.” — Nikki Fried (link)

The fix won’t be pretty, but it’s necessary

There’s a one-year fuse on this federal hemp ban. Fried thinks the message has to be simple and loud: regulate, don’t annihilate. Build a national framework for cannabinoid products that chokes off bad actors without suffocating the entire ecosystem. Give small farms a real shot. Don’t strand the legitimate hemp businesses that took Congress at its 2018 word. The political gears are already grinding: Hill staffers fielding constituent calls, trade associations gearing up for a long winter of briefings and hallway negotiations. If you’re looking for the pressure points, watch the scramble on the Hill described in Congressional Democratic Lawmakers Weigh Plans To Save Hemp Industry From Looming Federal Ban. And if you want to understand the deeper fault line—the collision between state innovation and federal overreach—consider the constitutional rumble beneath it all, the kind that’s drawing fresh attention in Libertarian Think Tank Urges Supreme Court To Hear Marijuana Case And Restore ‘Foundational’ Constitutional Principle. This isn’t just a hemp fight. It’s a test of how America reconciles a maturing cannabis economy with the federal government’s fondness for prohibition-era reflexes.

Rescheduling, descheduling, and the slow dance of reform

Hovering over the wreckage is the other federal storyline: marijuana rescheduling. Fried, never shy, argues the polling is clear—Americans want the war on weed retired. The difference between rescheduling and descheduling is the difference between rearranging the furniture and opening the doors: you might fix some banking headaches, but the bigger logjams—interstate commerce, insurance, 280E, real investment—still demand a full rethink. Trump campaigned on rescheduling. Now he’s the one with the pen. Political barometers in his world are often spelled P-O-L-L-S; if those numbers hold, change is still on the table. In the states, reform still gallops faster than Washington trudges. Florida’s adult-use push looks destined for a 2026 ballot showdown, even as Tallahassee gamesmanship tries to clip its wings. Elsewhere, the costs of policy whiplash are stacking up. Ask Michigan, where a courtroom is now the forum for tax-policy sanity in Michigan Court Hears Marijuana Industry Lawsuit Challenging New Tax Increase. Cannabis taxation, legal cannabis revenue, and economic development are now kitchen-table issues—and the courts are being dragged to dinner.

What comes next if Congress doesn’t blink

States will try to improvise around the federal hemp ban. They’ll erect new guardrails, patch loopholes, and craft boutique compliance regimes that look fine on paper and painful in practice. Without interstate commerce, it’s just a series of islands, each with its own tolls, each promising to be kinder to business until the headlines shift. The cannabis sector will keep arguing with itself—MSOs on one flank, hemp insurgents on the other—while consumers keep doing what they do: looking for consistent, safe products that don’t make their lives harder. Fried’s plea is for adults in the room to sit down, order strong coffee, and hammer out a framework that doesn’t pick winners and losers at 2 a.m. If Congress can’t stomach that, it should at least admit what this really is: a policy choice to crush small businesses while pretending to protect public health. That’s not reform. That’s a rerun.

In the end, this is why people hate government: not because it regulates, but because it flails—because it yo-yos livelihoods without owning the consequences. Picture the faces behind those spreadsheets: the farmer with a secondhand tractor, the night-shift lab tech checking COAs, the veteran who finally sleeps. They deserve better than a ban slipped under the door. The fix is obvious: craft a national standard for hemp-derived products, align it with broader marijuana policy reform, and let the market breathe while you police the bad actors. Until then, the cannabis industry will keep living at the mercy of the next “gotcha” amendment. If you want to navigate this shifting landscape with products that respect the line between compliance and quality, take a look at our shop: https://thcaorder.com/shop/.

Leave a Reply

Subscribe

Get Weekly Discounts & 15% Off Your 1st Order.

    FDA disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

    Please Note: Due to current state laws, we are unable to ship THCa products to the following states: Arkansas, Idaho, Minnesota, Oregon, Rhode Island.
    Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
    • Image
    • SKU
    • Rating
    • Price
    • Stock
    • Availability
    • Add to cart
    • Description
    • Content
    • Weight
    • Dimensions
    • Additional information
    Click outside to hide the comparison bar
    Compare
    Home
    Shopping
    Account